About Yacca Pharmaceuticals Private Limited
Data last updated:
Yacca Pharmaceuticals Private Limited is a private limited company based in Bulandshahr, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 December 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1989PTC011458. Its GSTIN is 05AAACY0893Q2ZP (Uttarakhand). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Pankaj Kumar Bansal (Managing Director) and Prateek Mohan Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 220/1 Hirapur Siyana Road Bulandshahr, Uttar Pradesh, India – 203001.
As per the financials filed for FY 2024, the company reported a revenue of ₹40.38 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹70.36 Lakh (net margin 1.7%) and EBITDA of ₹2.98 Cr (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 33% over five years.
The company has about 31 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Yacca Pharmaceuticals. As per MCA filings, the company has open charges of ₹49.02 Cr and satisfied charges of ₹4.48 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website yaccapharma.com.
Company details
Contact details
Yacca Pharmaceuticals Private Limited's registered office is in Bulandshahr, Uttar Pradesh. Its website is yaccapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address220/1 Hirapur Siyana Road Bulandshahr, Uttar Pradesh, India – 203001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Yacca Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Yacca Pharmaceuticals operates one associated brand: Yacca Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products such as tablets, capsules, syrup, and ointments. | yaccapharma.com |
Business activity
The main business activity of Yacca Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Yacca Pharmaceuticals Private Limited, buy the company report.
Financials of Yacca Pharmaceuticals Private Limited
FY 2024 filings availableYacca Pharmaceuticals Private Limited reported revenue of ₹40.38 Cr (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 6% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yacca Pharmaceuticals Private Limited, buy the company report.
Board of directors of Yacca Pharmaceuticals Private Limited
Yacca Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prateek Mohan Bansal Also directs: Yacca Lifesciences Private Limited, Indesol Global LLP | Director | 11 Aug 2018 | 8 Years 2 Months | Current |
| Aayush Mohan Bansal Also directs: Yacca Lifesciences Private Limited | Director | 11 Aug 2018 | 8 Years 2 Months | Current |
| Pankaj Kumar Bansal Also directs: Yacca Lifesciences Private Limited | Managing Director | 11 Dec 1989 | 36 Years 10 Months | Current |
| Anjali Bansal Also directs: Yacca Lifesciences Private Limited | Director | 11 Dec 1989 | 36 Years 10 Months | Current |
Peer comparison
Yacca Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viridis Biopharma Private Limited | ₹40.48 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Shree Anand Life Sciences Limited | ₹40.42 Cr (FY 2023) | -2.0% | Belgaum, Karnataka, India | |||
| Alas Pharmaceuticals Private Limited | ₹40.4 Cr (FY 2021) | Pune, Maharashtra, India | ||||
| Siflon Drugs and Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2025) | 38.0% | Hyderabad, Telangana, India | |||
| Yacca Pharmaceuticals Private Limitedthis company | ₹40.38 Cr (FY 2024) | ₹70.36 Lakh | 1.7% | 6.0% | 31 | Bulandshahr, Uttar Pradesh, India |
| Vindas Chemical Industries Private Limited | ₹40.36 Cr (FY 2025) | 74.0% | Dhar, Madhya Pradesh, India | |||
| Alkimia Pharma-Chem Private Limited | ₹40.2 Cr (FY 2025) | 975.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Yacca Pharmaceuticals Private Limited, buy the company report.
Auditor
Yacca Pharmaceuticals Private Limited is audited by NIRBHAYA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIRBHAYA & ASSOCIATES | FY 2023 | 016125N |
Shareholding
The shareholding of Yacca Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Yacca Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2022 | 100612073 | Others | ₹29.99 Cr | Open | |
| 16 Sep 2020 | 100388330 | Hdfc Bank Limited | ₹18.93 Cr | Open | |
| 16 May 1994 | 90278682 | Pankaj K. Bansal | ₹10 Lakh | Open | |
| 27 Nov 2019 | 100305438 | Others | ₹2.38 Cr | Satisfied | |
| 02 Jan 2016 | 10625306 | Hdfc Bank Limited | ₹2 Cr | Satisfied |
To see the full charge records of Yacca Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Yacca Pharmaceuticals Private Limited has 6 court cases on record: 5 filed by Yacca Pharmaceuticals, 1 filed against it. 2 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 1 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Arbitration matter | Filed by the company against Rajasthan Medical Services Corporation Ltd and 1 other | Pending |
| District court, Churu, Rajasthan | Court case (Complaint) | Filed against the company by State Through Seema Tanan, D.C.O | Pending |
| High Court, HIMACHAL PRADESH | Writ petition | Filed by the company against The State of HP and Others(Not Applicable) and 2 others | Disposed |
| High Court | Interim or miscellaneous application | Filed by the company against The State of HP and Others(Not Applicable) | Disposed |
| High Court, UTTARAKHAND | Court case (WPMS) | Filed by the company against Union of India and Others | Disposed |
To see the full case history of Yacca Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Yacca Pharmaceuticals Private Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 68 overdue payments to 56 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 56)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Roorkee Foils | |||
| an individual supplier | |||
| Apex Distributors | |||
| Blize Printers |
To see the full MSME payment records of Yacca Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Yacca Pharmaceuticals Private Limited has a workforce of 31 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Yacca Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACY0893Q2ZP | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Yacca Pharmaceuticals Private Limited, buy the company report.
Recent activity
Yacca Pharmaceuticals Private Limited has 4 board changes on record since 1989: 4 appointments. The latest: Aayush Mohan Bansal was appointed as Director on 11 Aug 2018.
10 earlier events are in the company report.
Frequently asked questions
Yacca Pharmaceuticals is an active private limited company based in Bulandshahr, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 December 1989 (37+ years old) and is registered under CIN U24231UP1989PTC011458.
Yacca Pharmaceuticals has 4 current directors:
- Pankaj Kumar Bansal - Managing Director
- Prateek Mohan Bansal - Director
- Aayush Mohan Bansal - Director
- Anjali Bansal - Director
The latest financial statements of Yacca Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Yacca Pharmaceuticals is 05AAACY0893Q2ZP, registered in Uttarakhand. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Yacca Pharmaceuticals is U24231UP1989PTC011458. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yacca Pharmaceuticals has 6 court cases on record: 5 filed by the company and 1 filed against it. 2 are pending. Most are in the high courts.
Yacca Pharmaceuticals was incorporated on 11 December 1989, making it 37+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Yacca Pharmaceuticals by revenue are Viridis Biopharma Private Limited, Shree Anand Life Sciences Limited, Alas Pharmaceuticals Private Limited, Siflon Drugs and Pharmaceuticals Private Limited, Vindas Chemical Industries Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aayush Mohan Bansal was appointed as Director on 11 Aug 2018. Prateek Mohan Bansal was appointed as Director on 11 Aug 2018. Anjali Bansal was appointed as Director on 11 Dec 1989. Yacca Pharmaceuticals has 4 board changes on record in total.
Yacca Pharmaceuticals has 6 MSME Form 1 returns on record between 2019 and 2022, listing 68 overdue payments to 56 micro and small suppliers. The latest return was filed on 25 May 2022.
Yacca Pharmaceuticals can be reached through the website yaccapharma.com. Its registered office is in Bulandshahr, Uttar Pradesh, India.
The registered office of Yacca Pharmaceuticals is at 2201 Hirapur Siyana Road Bulandshahr, Uttar Pradesh, India – 203001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
